Bioventures Institutesp. z o.o.
Research and experimental development on biotechnology
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 708 days for 2021).
- 2025not filed
- 202422/07/2025
- 202322/07/2025
- 202225/06/2024
- 202122/06/2024
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Trademarks
Bioventures Institute currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| BIOVENTURES INSTITUTE | – |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, two members of the management board acting jointly (including the Vice-President if appointed) are authorised to make declarations of will on behalf of the company, and in the case of a one-person management board, one member of the management board independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Łukasz Janusage 43 | 11 | $415.99 | 20.3704% |
Piotr Skowronage 64 | 13 | $491.63 | 24.0741% |
Grzegorz Władysław Węgrzynage 63 | 6 | $226.90 | 11.1111% |
Others | 24 | $907.62 | 44.4444% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2026-09-01.
27 1020 4027 0000 1302 1326 7457- 33 1020 4027 0000 1602 1086 4124
- 84 1020 4027 0000 1902 1167 4464
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 10, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $35,696$35,696 | Excento sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-03-02 | Share capital increase (7,000.00 PLN → 7,560.00 PLN) | |
| 2015-09-04 | Share capital increase (6,050.00 PLN → 7,000.00 PLN) | |
| 2014-04-25 | Share capital increase (5,000.00 PLN → 6,050.00 PLN) | |
| 2014-04-25 | PKD change (Removed: 29 codes) | |
| 2011-04-12 | Name change (Ecdf Innowacje → Bioventures Institute) |
FAQ
Last updated: 2026-04-18